Therefore, incorporation of a therapeutic gene into the LV-CD68-YFP vector was considered to deliver more therapeutic gene expression to the spinal cord of ALS mice as the disease progresses. The gene discussed is CD68; the disease is amyotrophic lateral sclerosis.